Our central location for research news and other stories of related information can be found here.

Tuesday, May 24, 2011

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

"The PROMUS Stent has demonstrated outstanding deliverability, low late loss and excellent safety in numerous clinical trials and extensive real-world practice," said Dean J. Kereiakes, MD, FACC, Medical Director, The Christ Hospital Heart and Vascular Center and The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, and Professor of Clinical Medicine, Ohio State University.  "These benefits make the PROMUS 2.25 mm Stent an attractive option for U.S. physicians treating patients with small vessels."

Read the full story

Tuesday, May 10, 2011

Cardiologists with The Christ Hospital are First in Greater Cincinnati Region to Perform Heart Valve Replacement without Open Heart Surgery

Physicians at The Christ Hospital are first to bring pioneering technology to Greater Cincinnati that may provide a treatment option for patients with a common heart valve disorder who do not qualify for surgery. The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital (Lindner Research Center) is one of 20+ sites in the U.S. to participate in an investigational research trial using a novel therapy to treat severe aortic stenosis (AS), a condition that affects nearly 1.5 million Americans. The PARTNER (Placement of AoRTic traNscathetER valves) II Trial will evaluate transcatheter aortic valve replacement (TAVR), using the Edwards SAPIEN XT valve, in patients who are considered to be at high risk or inoperable for traditional valve replacement using open-heart surgery. The Christ Hospital is the only PARTNER II study site between Cleveland, Oh. and Atlanta, Ga.

Read the full story